Chen L, Yin Q, Zhang H, Zhang J, Yang G, Weng L
Adv Sci (Weinh). 2024; 11(46):e2309053.
PMID: 39467056
PMC: 11633475.
DOI: 10.1002/advs.202309053.
Menditti D, Santagata M, Guida D, Magliulo R, DAntonio G, Stagliano S
Bioengineering (Basel). 2024; 11(3).
PMID: 38534502
PMC: 10967966.
DOI: 10.3390/bioengineering11030228.
Khan S, Song B, Mallidi S, Li S, Liu H, Bilal Hussain M
J Biomed Opt. 2023; 28(8):082809.
PMID: 37483565
PMC: 10362156.
DOI: 10.1117/1.JBO.28.8.082809.
Xiao Q, Wang L, Zhang J, Zhong X, Guo Z, Yu J
Biomolecules. 2022; 12(10).
PMID: 36291598
PMC: 9599573.
DOI: 10.3390/biom12101389.
Siddiqui S, Siddiqui S, Bilal Hussain M, Khan S, Liu H, Akhtar K
Photodiagnosis Photodyn Ther. 2022; 38:102843.
PMID: 35367616
PMC: 9177774.
DOI: 10.1016/j.pdpdt.2022.102843.
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
Takahashi J, Nagasawa S, Doi M, Takahashi M, Narita Y, Yamamoto J
Int J Mol Sci. 2021; 22(18).
PMID: 34575921
PMC: 8470662.
DOI: 10.3390/ijms22189762.
Perspectives on interstitial photodynamic therapy for malignant tumors.
Komolibus K, Fisher C, Swartling J, Svanberg S, Svanberg K, Andersson-Engels S
J Biomed Opt. 2021; 26(7).
PMID: 34302323
PMC: 8299827.
DOI: 10.1117/1.JBO.26.7.070604.
Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.
Traylor J, Pernik M, Sternisha A, McBrayer S, Abdullah K
Cancers (Basel). 2021; 13(3).
PMID: 33540759
PMC: 7867275.
DOI: 10.3390/cancers13030580.
Comprehensive review of surgical microscopes: technology development and medical applications.
Ma L, Fei B
J Biomed Opt. 2021; 26(1).
PMID: 33398948
PMC: 7780882.
DOI: 10.1117/1.JBO.26.1.010901.
Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.
Verebova V, Benes J, Stanicova J
Molecules. 2020; 25(23).
PMID: 33271809
PMC: 7731333.
DOI: 10.3390/molecules25235666.
Sulphur-doped carbon dots as a highly efficient nano-photodynamic agent against oral squamous cell carcinoma.
Li Q, Zhou R, Xie Y, Li Y, Chen Y, Cai X
Cell Prolif. 2020; 53(4):e12786.
PMID: 32301195
PMC: 7162798.
DOI: 10.1111/cpr.12786.
Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer.
Khan S, Bilal Hussain M, Khan A, Liu H, Siddiqui S, Mallidi S
J Biomed Opt. 2020; 25(6):1-10.
PMID: 32279466
PMC: 7148420.
DOI: 10.1117/1.JBO.25.6.063813.
Verification of 5-Aminolevurinic Radiodynamic Therapy Using a Murine Melanoma Brain Metastasis Model.
Takahashi J, Nagasawa S, Ikemoto M, Sato C, Sato M, Iwahashi H
Int J Mol Sci. 2019; 20(20).
PMID: 31627442
PMC: 6834170.
DOI: 10.3390/ijms20205155.
Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings.
Liu H, Daly L, Rudd G, Khan A, Mallidi S, Liu Y
Lasers Surg Med. 2018; 51(4):345-351.
PMID: 30168618
PMC: 6934354.
DOI: 10.1002/lsm.23019.
Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model.
Takahashi J, Murakami M, Mori T, Iwahashi H
Sci Rep. 2018; 8(1):2728.
PMID: 29426920
PMC: 5807383.
DOI: 10.1038/s41598-018-21152-z.
.
Betz C, Leunig A
HNO. 2017; 52(2):175-192.
PMID: 28246683
DOI: 10.1007/s00106-003-1029-1.
Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.
Burgess L, Chen J, Wolter N, Wilson B, Zheng G
Biomed Opt Express. 2016; 7(3):1089-99.
PMID: 27231609
PMC: 4866449.
DOI: 10.1364/BOE.7.001089.
Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.
Ahn P, Quon H, OMalley B, Weinstein G, Chalian A, Malloy K
Oral Oncol. 2016; 55:37-42.
PMID: 26865261
PMC: 4943020.
DOI: 10.1016/j.oraloncology.2016.01.013.
Ambient Light Promotes Selective Subcellular Proteotoxicity after Endogenous and Exogenous Porphyrinogenic Stress.
Maitra D, Elenbaas J, Whitesall S, Basrur V, DAlecy L, Omary M
J Biol Chem. 2015; 290(39):23711-24.
PMID: 26205816
PMC: 4583010.
DOI: 10.1074/jbc.M114.636001.
Applications of calixarenes in cancer chemotherapy: facts and perspectives.
Yousaf A, Abd Hamid S, Bunnori N, Ishola A
Drug Des Devel Ther. 2015; 9:2831-8.
PMID: 26082613
PMC: 4459628.
DOI: 10.2147/DDDT.S83213.